“Belimumab in Lupus Nephritis Patients with Impaired Renal Function: A Post-Hoc Analysis of the Bliss-LN Trial” (2025) Epidemiology, Biostatistics, and Public Health [Preprint]. doi:10.54103/2282-0930/29538.